BACKGROUND: Increased left atrial diameter (LAD) is associated with elevated risk of atrial fibrillation (AF) and cardiovascular disease. Information is limited regarding the short- or long-term correlates of LAD. METHODS AND RESULTS: We evaluated clinical correlates of LAD for a 16-year period in 4403 Framingham Study participants (mean age, 45 years; 52% women; median observations/participant=3) using multilevel modeling. We related age, sex, body mass index (BMI), systolic and diastolic blood pressure (BP), diabetes, and antihypertensive treatment to LAD. Sex-specific growth curves for LAD were estimated for individuals with low, intermediate, and high risk factor burden. We also related risk factors to changes in LAD during a 4-year period in 3365 participants. Age, male sex (3.83 mm compared to women), greater BMI, higher systolic BP (0.24 mm per 10 mm Hg increment), and antihypertensive treatment (0.54 mm) were associated positively with LAD (P<0.001). Men had a greater increase in LAD with BMI than women (2.02 versus 1.77 mm in women, per 5-unit increment), and individuals receiving antihypertensive treatment experienced a greater increase in LAD with age (0.95 versus 0.63 mm per 10-year age increment) when compared with those not receiving antihypertensive treatment. Overall, greater risk factor burden was positively associated with LAD. These risk factors were also associated positively with 4-year change in LAD (P<0.001). CONCLUSIONS: Our longitudinal study of a large community-based sample identified higher BP and greater BMI as key modifiable correlates of LAD, suggesting that maintaining optimal levels of these risk factors through the life course may prevent atrial remodeling and AF.
BACKGROUND: Increased left atrial diameter (LAD) is associated with elevated risk of atrial fibrillation (AF) and cardiovascular disease. Information is limited regarding the short- or long-term correlates of LAD. METHODS AND RESULTS: We evaluated clinical correlates of LAD for a 16-year period in 4403 Framingham Study participants (mean age, 45 years; 52% women; median observations/participant=3) using multilevel modeling. We related age, sex, body mass index (BMI), systolic and diastolic blood pressure (BP), diabetes, and antihypertensive treatment to LAD. Sex-specific growth curves for LAD were estimated for individuals with low, intermediate, and high risk factor burden. We also related risk factors to changes in LAD during a 4-year period in 3365 participants. Age, male sex (3.83 mm compared to women), greater BMI, higher systolic BP (0.24 mm per 10 mm Hg increment), and antihypertensive treatment (0.54 mm) were associated positively with LAD (P<0.001). Men had a greater increase in LAD with BMI than women (2.02 versus 1.77 mm in women, per 5-unit increment), and individuals receiving antihypertensive treatment experienced a greater increase in LAD with age (0.95 versus 0.63 mm per 10-year age increment) when compared with those not receiving antihypertensive treatment. Overall, greater risk factor burden was positively associated with LAD. These risk factors were also associated positively with 4-year change in LAD (P<0.001). CONCLUSIONS: Our longitudinal study of a large community-based sample identified higher BP and greater BMI as key modifiable correlates of LAD, suggesting that maintaining optimal levels of these risk factors through the life course may prevent atrial remodeling and AF.
Authors: T S Tsang; M E Barnes; K R Bailey; C L Leibson; S C Montgomery; Y Takemoto; P M Diamond; M A Marra; B J Gersh; D O Wiebers; G W Petty; J B Seward Journal: Mayo Clin Proc Date: 2001-05 Impact factor: 7.616
Authors: Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse Journal: Circulation Date: 2009-02-03 Impact factor: 29.690
Authors: Nikolas Wanahita; Franz H Messerli; Sripal Bangalore; Apoor S Gami; Virend K Somers; Jonathan S Steinberg Journal: Am Heart J Date: 2007-12-19 Impact factor: 4.749
Authors: Susan R Heckbert; Kerri L Wiggins; Nicole L Glazer; Sascha Dublin; Bruce M Psaty; Nicholas L Smith; W T Longstreth; Thomas Lumley Journal: Am J Hypertens Date: 2009-03-05 Impact factor: 2.689
Authors: Jan Heeringa; Jan A Kors; Albert Hofman; Frank J A van Rooij; Jacqueline C M Witteman Journal: Am Heart J Date: 2008-10-14 Impact factor: 4.749
Authors: Nisha I Parikh; Michael J Pencina; Thomas J Wang; Emelia J Benjamin; Katherine J Lanier; Daniel Levy; Ralph B D'Agostino; William B Kannel; Ramachandran S Vasan Journal: Ann Intern Med Date: 2008-01-15 Impact factor: 25.391
Authors: Renate B Schnabel; Lisa M Sullivan; Daniel Levy; Michael J Pencina; Joseph M Massaro; Ralph B D'Agostino; Christopher Newton-Cheh; Jennifer F Yamamoto; Jared W Magnani; Thomas M Tadros; William B Kannel; Thomas J Wang; Patrick T Ellinor; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin Journal: Lancet Date: 2009-02-28 Impact factor: 79.321
Authors: M C Thomas; S Dublin; R C Kaplan; N L Glazer; T Lumley; W T Longstreth; N L Smith; B M Psaty; D S Siscovick; S R Heckbert Journal: Am J Hypertens Date: 2008-08-28 Impact factor: 2.689
Authors: Wesley T O'Neal; Hooman Kamel; Suzanne E Judd; Monika M Safford; Viola Vaccarino; Virginia J Howard; George Howard; Elsayed Z Soliman Journal: Am J Cardiol Date: 2017-06-15 Impact factor: 2.778
Authors: Raghava S Velagaleti; Philimon Gona; Michael J Pencina; Jayashri Aragam; Thomas J Wang; Daniel Levy; Ralph B D'Agostino; Douglas S Lee; William B Kannel; Emelia J Benjamin; Ramachandran S Vasan Journal: Am J Cardiol Date: 2013-10-04 Impact factor: 2.778
Authors: David Conen; Robert J Glynn; Roopinder K Sandhu; Usha B Tedrow; Christine M Albert Journal: Int J Cardiol Date: 2013-01-17 Impact factor: 4.164